Norges Bank’s Ocular Therapeutix OCUL Stock Holding History

Norges Bank’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-73,007	Closed	-$886K	–	950
2025 Q4	$886K	Buy	+73,007	New	+$887K	﹤0.01%	1526
2023 Q3	–	Sell	-119,500	Closed	-$617K	–	2015
2023 Q2	$617K	Sell	119,500 -374,800	-76%	-$2.23M	﹤0.01%	1958
2023 Q1	$2.6M	Buy	+494,300	New	+$2.35M	﹤0.01%	1891

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Norges Bank's OCUL Position: Q1 2026 in Review

Norges Bank sold out of Ocular Therapeutix (OCUL) in Q1 2026, closing a stake of 73,007 shares — an estimated $886K sold.

Norges Bank first reported a position in OCUL in Q1 2023 and held it in 3 quarters. The position peaked at $2.6M in Q1 2023. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

Norges Bank reported no remaining Ocular Therapeutix position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 73,007 Ocular Therapeutix shares in Q1 2026, an estimated $886K.
Norges Bank first reported a position in Ocular Therapeutix in Q1 2023 and held it in 3 quarters.
Norges Bank's Ocular Therapeutix position peaked at $2.6M in Q1 2023.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.